These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 23320610

  • 21. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD, Kleit AN, Nietert PJ, Ornstein S.
    Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [Abstract] [Full Text] [Related]

  • 22. Approach to addressing missing data for electronic medical records and pharmacy claims data research.
    Bounthavong M, Watanabe JH, Sullivan KM.
    Pharmacotherapy; 2015 Apr; 35(4):380-7. PubMed ID: 25884526
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of a packaging approach to improve cholesterol medication adherence.
    Bosworth HB, Brown JN, Danus S, Sanders LL, McCant F, Zullig LL, Olsen MK.
    Am J Manag Care; 2017 Sep 01; 23(9):e280-e286. PubMed ID: 29087166
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE.
    Curr Med Res Opin; 2007 Sep 01; 23(9):2125-33. PubMed ID: 17655813
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP, Mikhailidis DP, Moross T, Benson K, Gor M.
    Angiology; 2008 Sep 01; 59(1):36-46. PubMed ID: 18319220
    [Abstract] [Full Text] [Related]

  • 33. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW, Liem AH, Dunselman PH, van der Sloot JA, Lok DJ, Zwinderman AH.
    Curr Med Res Opin; 2005 Nov 01; 21(11):1865-74. PubMed ID: 16307708
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Daskalopoulou SS, Kakafika AI, Pehlivanidis AN, Bouloukos VI, Langer A, GREACE Study Collaborative Group.
    Curr Med Res Opin; 2004 Sep 01; 20(9):1385-92. PubMed ID: 15383187
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lipid profile changes associated with changing available formulary statins: removing higher potency agents.
    Longyhore DS, Stockton CM, Thomas MR.
    Am J Manag Care; 2009 Jul 01; 15(7):409-14. PubMed ID: 19589008
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.